A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)

Clinical trial NCT06809595 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06809595
Sponsor: Definium Therapeutics US, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Generalized Anxiety Disorder

Start date: 2025-01-29
Primary completion: 2026-08-01
Enrollment: 245

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.